3. Appendix.8.1
Total Page:16
File Type:pdf, Size:1020Kb
Appendix A The USTA Anti-Doping Program The USTA is committed to ensuring fair and drug-free competition. Individual athletes bear the ultimate responsibility to choose for themselves to compete fairly and drug-free. Participation in USTA tournaments constitutes consent to be tested for drugs. Use of banned substances and doping methods is cheating and may result in penal- ties, including suspension and permanent disqualification. The USTA has developed a program of education, testing, research, penalties, and rehabilitation to maintain the integrity of tennis and protect the health and rights of all tennis players. The USTA Board of Directors has adopted and supports the USTA Anti-Doping Program. Information about the program may be obtained from the USA Tennis Sport Science Department and your local USTA section. It can also be viewed on the USTA Web site at www.usta.com under USA Tennis/USA Tennis Player Development. Further information can be obtained by calling 888-354-8782. DEFINITIONS* alcohol—a drug that depresses the central nervous system and af- fects coordination and fine hand-eye movements. Nevertheless, breath or blood alcohol levels may be determined at the request of the *Some of these definitions were adapted with permission from the United States Anti-Doping Agency (USADA), Colorado Springs, Colorado. 58 The USTA Anti-Doping Program responsible authorities (i.e., WADA, IOC, NOC, USOC, IF, and/or NGB), and positive tests may lead to sanctions. Alcohol is the most widely abused drug in the country, yet it does not generally improve sports performance. anabolic agents—a prohibited class of agents made up of the male hormone testosterone and its synthetic derivatives. Natural testosterone regulates, promotes, and maintains physical and sexual development. Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) medications—the most commonly prescribed medications (e.g., Ritalin and Cylert) to treat ADD and ADHD that contain prohibited stimulants. Athletes who are pre- scribed these medications should consult their physician and National Governing Body as soon as possible. The USTA rule allows for a Request for Medical Exemption to be filed by the player’s physician; if granted, the athlete is allowed to use the prohibited substance. blood doping—the administration of blood, red blood cells, and re- lated blood products to an athlete, which may be preceded by with- drawal of blood from the athlete, who continues to train in such a blood-depleted state. caffeine—a central nervous system stimulant that is found in coffee, tea, chocolate, and soft drinks. Many cough and cold supple- ments and pain reliever combinations also contain caffeine. A concen- tration greater than 12 micrograms of caffeine per milliliter (12 mcg/ml) in the urine is considered doping. A few cups of typical, American-brewed coffee should not result in a urinary concentration greater than 12 mcg/ml. cannabinoids—substances constituted of marijuana, hashish, or cannabis that contain mind-altering ingredients. Possession and/or use of these substances are illegal and may subject a person to arrest and criminal prosecution. The International Olympic Committee at the Olympic Games and many International Federations include cannabinoids on their list of prohibited substances. In those cases, a concentration in the urine of carboxy-THC greater than 15 nanograms per milliliter constitutes doping. The body absorbs THC, which is the mind-altering ingredient in cannabinoids, and transforms it into metabolites, which can be detected in the urine for weeks after use. 59 USA Tennis Parents’ Guide The metabolites can be detected in urine 4 to 10 days after smoking a single joint, and up to several weeks or months following chronic use. At the Olympic Games, tests are conducted for cannabinoids. creatine—a natural compound that is an important part of the body’s energy storage system. Energy is stored in the cells as creatine phosphate. Creatine is obtained primarily from meat in the diet. The long-term effects of taking supplemental creatine have not yet been established, but there appears to be a greater incidence of dehydra- tion, nausea, stomach cramps, diarrhea, muscle cramping, pulled muscles, and muscle tightness, according to a survey of creatine users. There are also two published reports of individuals with pre-existing liver and kidney problems having further complications while using creatine. diuretics—drugs that help the body to eliminate fluids (water and salts) by increasing the rate of urine formation. EPO (Erythropoietin)—a hormone produced by the kidneys to cause the production of new red blood cells in the bone marrow. Red blood cells carry oxygen from the lungs to the tissues, so high levels of EPO can increase the number of red blood cells, which can increase the amount of oxygen available to the tissues. growth hormone (hGH, Somatotropin)—a hormone secreted by the pituitary gland that exerts many effects on the human body. It plays an important role in a child’s development as well as in adapting to the stress of resistance training. Its use is dangerous and may result in various adverse effects: allergic reactions, diabetes, and acromegaly. Contamination of some growth hormone preparations of human origin can cause Creutzfeldt Jacob Disease, a fatal neurological condition. The hormone hGH is produced by the body to increase muscle, bone, and other tissue size. It is most active during growth spurts in teenagers. After a person stops growing, it aids in maintaining muscle mass. In high doses after growth cessation, it has harmful effects on internal tissues such as the liver. narcotics—a class of medications with effects of pain reduction and tendencies for psychological and physiological addiction. stimulant—any substance that temporarily increases body func- tions or activities. 60 The USTA Anti-Doping Program For further information, obtain the USADA (United States Anti- Doping Agency) Guide to Prohibited Classes of Substances and Prohibited Methods of Doping. To contact the United States Anti- Doping Agency (USADA), call 1-866-601-2632, or visit their Web site at www.usantidoping.org. Further information can be obtained by calling Managed Athletic Testing Services (MATS) at 1-800-994-4504 or 1-561- 367-9484. You can also contact the USTA Sport Science Department at 1-888-354-8782 for the latest rulings on these substances. 61 Appendix B Resource Guide USTA OFFICES USTA, 70 West Red Oak Lane, White Plains, NY 10604. Tel: (914) 696-7000; Fax: (914) 696-7167 USTA Bookstore: Tel: (888) 832-8291 USA Tennis Player Development, 7310 Crandon Blvd., Key Biscayne, FL 33149. Tel: (305) 365-USTA (8782); Fax: (305) 365-8700 Coaching Education, Tel: (305) 365-8702 Junior Competition, Tel: (305) 365-8716 Sport Science, Tel: (305) 365-8707, (888) 354-8782 USTA Anti-Doping Program, Tel: (888) 354-8782; E-mail: [email protected] USTA National Tennis Center, Flushing Meadows Corona Park, Flushing, NY 11368. Tel: (718) 760-6200; Fax: (718) 592-9488 RELATED ORGANIZATIONS American Sport Education Program (ASEP), P. O. Box 5076, Champaign, IL 61825. Tel: (800) 747-5698; Fax: (217) 351-2674 62 Resource Guide ATP, 200 ATP Boulevard, Ponte Vedra Beach, FL 32082. Tel: (904) 285-8000; Fax: (904) 285-5966 Europe, Monte Carlo Sun, 74 Boulevard D’ Italie, 98000 Monaco. Tel: 377-97970404; Fax: 377-97970400 International Group, Level 6, 20 Alfred Street, Milsons Point, Sydney, New South Wales 2061. Tel: 612-9964-9900; Fax: 612-9964-9977 Human Kinetics, P. O. Box 5076, Champaign, IL 61825. Tel: (217) 351-5076, (800) 747-4457; Fax: (217) 351-2674 International Tennis Federation (ITF), Bank Lane, Roehampton, London, SW15 5XZ, England. Tel: 44 2088786464; Fax: 44 2088787799 ITF Anti-Doping Information, Tel: 44 2088786464; Fax: 44 2088787799; E-mail: [email protected] ITF Development Department, Fax: 44 2083924742; E-mail: [email protected] ITF Juniors Department, Fax: 44 2083924735; E-mail: [email protected] LGE Performance Systems, Inc., 9757 Lake Nona Road, Orlando, FL 32827. Tel: (407) 438-9911; Fax: (407) 438-6667 Managed Athletic Testing Services (MATS), 4800 North Federal Highway, Suite 205-B, Boca Raton, FL 33431. Tel: (561) 367-9484, (800) 994-4504; Fax: (561) 367-8186 National Youth Sports Safety Foundation, 333 Longwood Avenue, Suite 202, Boston, MA 02115. Tel: (617) 277-1171; Fax: (617) 277-2278; E-mail: [email protected] Northeastern University, Center for the Study of Sport in Society, 360 Huntington Avenue, Suite 161CP, Boston, MA 02115-5000. Tel: (617) 373-4025; Fax: (617) 373-4566; c/o Disney’s Sports and Recreation, P.O. Box 10,000, Lake Buena Vista, FL 32830. Tel: (407) 397-6359; Fax: (407) 397-6400; E-mail: [email protected] Professional Tennis Registry (PTR), P. O. Box 4739, Hilton Head, SC 29938. Tel: (800) 421-6289 or (843) 785-7244; Fax: (843) 686-2033 United States Anti-Doping Agency (USADA), 1265 Lake Plaza Drive, Colorado Springs, CO 80906. Tel: (719) 785-2000; Fax: (719) 785-2001 63 USA Tennis Parents’ Guide Drug Reference Line, Tel: (800) 233-0393 Toll Free Number, Tel: (866) 601-2632 United States Professional Tennis Association (USPTA), One USPTA Centre, 3535 Briarpark Drive, Suite One, Houston, TX 77042-5235. Tel: (713) 97-USPTA, (800) 877-8248; Fax: (713) 978-7780 World Anti-Doping Agency (WADA), Avenue du Tribunal-Federal 34, 1005 Lausanne, Switzerland. Tel: 41213510225; Fax: 41213291505 WTA Tour, 1266 East Main St., Fourth Floor, Stamford, CN 06902. Tel: (203) 978-1740; Fax: 203-978-1702 European Headquarters, Bank Lane, Roehampton, London, SW 15 5XZ, England. Tel: 44208392476; Fax: 442083924765 Worldwide OPS, 133 First Street N.E., St. Petersburg, FL. 33701. Tel: (727) 895-5000; Fax: (727) 894-1982 HELPFUL WEB SITES The Sport Science competency exams and information about the USTA Anti-Doping Program can be obtained from the USTA Web site (www.usta.com) under USA Tennis/USA Tennis Player Development/ Sport Science.